Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
November 13, 2018	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-18-325475.pdf 0001193125-18-325475.rtf View HTML
November 8, 2018	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001564590-18-028587.pdf 0001564590-18-028587.rtf 0001564590-18-028587.xls EX-101.INS - XBRL INSTANCE DOCUMENT View HTML
October 30, 2018	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	0001193125-18-312414.pdf 0001193125-18-312414.rtf 0001193125-18-312414.xls View HTML
October 30, 2018	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-18-312434.pdf 0001193125-18-312434.rtf 0001193125-18-312434.xls View HTML
October 30, 2018	EFFECT	EFFECT	9999999995-18-002755.pdf 9999999995-18-002755.rtf View HTML
October 29, 2018	S-4/A	Pre-effective amendment to an S-4 filing	0001193125-18-309873.pdf 0001193125-18-309873.rtf 0001193125-18-309873.xls View HTML
October 29, 2018	425	Filing of certain prospectuses and communications in connection with business combination transactions	0001193125-18-310776.pdf 0001193125-18-310776.rtf View HTML
October 29, 2018	CORRESP	CORRESP	0001193125-18-309877.pdf 0001193125-18-309877.rtf 0001193125-18-309877.xls View HTML
October 29, 2018	CORRESP	CORRESP	0001193125-18-309879.pdf 0001193125-18-309879.rtf 0001193125-18-309879.xls View HTML
October 26, 2018	UPLOAD	UPLOAD	0000000000-18-033597.pdf 0000000000-18-033597.rtf View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax